Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08JMI
|
||||
Former ID |
DCL001139
|
||||
Drug Name |
ALN-VSP
|
||||
Drug Type |
RNAi therapeutics
|
||||
Indication | Liver cancer [ICD9: 140-229, 155, 203.0; ICD10:C22] | Phase 1 | [550232] | ||
Company |
Alnylam Pharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | mRNA of kinesin spindle protein | Target Info | [550232] | ||
WikiPathways | MHC class II antigen presentation | ||||
Kinesins | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.